S
TAK icon

SimplyRich’s Takeda Pharmaceutical TAK Stock Holding History

SimplyRich’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$568K Sell
30,702
-437
-1% -$7.67K 0.15% 141
2025
Q4 		$485K Sell
31,139
-984
-3% -$14.1K 0.13% 139
2025
Q3 		$470K Sell
32,123
-397
-1% -$5.9K 0.13% 142
2025
Q2 		$502K Sell
32,520
-2,151
-6% -$31.8K 0.14% 141
2025
Q1 		$515K Buy
34,671
+14,999
+76% +$210K 0.15% 138
2024
Q4 		$260K Sell
19,672
-703
-3% -$9.66K 0.07% 198
2024
Q3 		$289K Buy
+20,375
New +$289K 0.08% 186
2024
Q2 		– Sell
-25,245
Closed -$351K – 186
2024
Q1 		$351K Buy
+25,245
New +$367K 0.11% 136
2023
Q4 		– Sell
-16,191
Closed -$250K – 178
2023
Q3 		$250K Buy
+16,191
New +$251K 0.12% 130

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return